Artemisinin Antimalarial Drugs Market size was USD 702.5 million in 2024 and is estimated to reach USD 1.24 billion by the end of 2037, expanding at a CAGR of 4.5% during the forecast period, i.e., 2025-2037. In 2025, the industry size of artemisinin antimalarial drugs is assessed at USD 734.1 million.
The increasing prevalence of malaria is primarily augmenting the market growth worldwide. Underdeveloped and developing countries are mainly witnessing issues related to diseases caused by mosquitoes. For instance, according to a report by the World Health Organization (WHO), there were around 249 million cases of malaria, globally, in 2022. Such statistics underscore the need for effective treatment options, fuelling the market growth.
Africa is the most prevalent region for malaria, accounting for 94.0% of all malaria cases in 2022. The governments in the region are implementing several initiatives to increase disease awareness and care, this is generating lucrative opportunities for artemisinin antimalarial drug manufacturers.
Author Credits: Radhika Pawar
Copyright © 2024 Research Nester. All Rights Reserved
FREE Sample Copy includes market overview, growth trends, statistical charts & tables, forecast estimates, and much more.
Have questions before ordering this report?